EUVIMEDEUVIMED entdecken
Crossref

A 64 Cu‐Labeled Oxopurine Derivative for Translocator Protein–Targeted Inflammation Imaging

Undram Ochirsukh, Iqra Bibi, Ho Young Kim, In Ok Ko, Kyung Jun Kang, Hyun Ji Lee, Kwang Il Kim, Ji-Ae Park iD, Jung Young Kim

Journal of Labelled Compounds and Radiopharmaceuticals · 2026-06 · 69 (7-8)

DOI: 10.1002/jlcr.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 02.06.2026. Verfasst von Undram Ochirsukh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Applied RI, Korea Institute of Radiological & Medical Sciences (KIRAMS), Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Copper Radioisotopes, Inflammation, Receptors, GABA. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Korea Institute of Radiological & Medical Sciences (KIRAMS), Korea Institute of Radiological and Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The translocator protein (TSPO) is a mitochondrial biomarker overexpressed in activated immune cells and various tumors that is an attractive target for positron emission tomography (PET) imaging of inflammation and the tumor microenvironment. We designed and evaluated the novel TSPO‐targeted PET tracer, 64 Cu‐purine ([ 64 Cu] 5 ), constructed from a purine scaffold conjugated to a NOTA chelator. Molecular docking analysis indicated that the DOTA analog exhibited slightly higher TSPO binding affinity than did the NOTA derivative; however, the NOTA chelator was selected for 64 Cu labeling due to its superior radiochemical yield and stability. [ 64 Cu] 5 demonstrated high radiochemical purity, excellent in vitro and in vivo stability, and moderate lipophilicity, which minimized nonspecific uptake. In vitro, [ 64 Cu] 5 showed significantly higher uptake in inflammatory macrophages than in tumor cells. In vivo PET imaging and biodistribution studies revealed preferential accumulation in inflamed and tumor tissues, with reduced uptake following PK11195 administration. Autoradiography and immunohistochemistry confirmed tracer accumulation in both inflamed and tumor tissues, reflecting the presence of inflammation within the tumor microenvironment. Overall, these findings suggest that [ 64 Cu] 5 is a promising TSPO‐targeting PET radiotracer for imaging inflammation‐associated processes in tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyCopper RadioisotopesInflammationReceptors, GABAPurinesRadiopharmaceuticalsAnimalsMiceTissue DistributionHumansIsotope Labeling

Stichwörter der Autor:innen

64CuPETTSPOinflammationoxopurine

Substanzen

Copper RadioisotopesReceptors, GABAPurinesRadiopharmaceuticalsCopper-64

Autor:innen und Institutionen

  • Division of Applied RI, Korea Institute of Radiological & Medical Sciences (KIRAMS), Seoul, Republic of Korea.
  • Graduate School of Medical Science (SeoulTech-KIRAMS), Seoul National University of Science and Technology, Seoul, Republic of Korea.
  • Radiological and Medico-Oncological Sciences, University of Science and Technology (UST), Daejeon, Republic of Korea.

ORCID-Profile: Ji-Ae Park

Förderung

  • Korea Institute of Radiological & Medical Sciences (KIRAMS)
  • Korea Institute of Radiological and Medical Sciences

Zitieren

APA

Ochirsukh, U., Bibi, I., Kim, H. Y., Ko, I. O., Kang, K. J., Lee, H. J., Kim, K. I., Park, J. A., & Kim, J. Y. (2026). A 64 Cu‐Labeled Oxopurine Derivative for Translocator Protein–Targeted Inflammation Imaging. Journal of Labelled Compounds and Radiopharmaceuticals, 69(7-8). https://doi.org/10.1002/jlcr.70032

Vancouver

Ochirsukh U, Bibi I, Kim HY, Ko IO, Kang KJ, Lee HJ, et al. A 64 Cu‐Labeled Oxopurine Derivative for Translocator Protein–Targeted Inflammation Imaging. Journal of Labelled Compounds and Radiopharmaceuticals. 2026;69(7-8). doi:10.1002/jlcr.70032

BibTeX
@article{Ochirsukh2026,
  author = {Ochirsukh, Undram and Bibi, Iqra and Kim, Ho Young and Ko, In Ok and Kang, Kyung Jun and Lee, Hyun Ji and Kim, Kwang Il and Park, Ji-Ae and Kim, Jung Young},
  title = {A 64 Cu‐Labeled Oxopurine Derivative for Translocator Protein–Targeted Inflammation Imaging},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2026},
  volume = {69},
  number = {7-8},
  doi = {10.1002/jlcr.70032}
}
Kostenlos starten →